Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

NCT04262154 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: Atezolizumab
DRUG: Abiraterone
DRUG: Prednisone
DRUG: GnRH analog
RADIATION: Stereotactic Body Radiotherapy (SBRT)
DRUG: Enzalutamide
OTHER: Follow up

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]